Hadasit Bio (Israel) Management Performance Evaluation

HDST -- Israel Stock  

ILS 455.00  0.00  0.00%

Analysis of Hadasit Bio manpower and management performance that can provide insight into the company performance. Note, an employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Hadasit Bio Holdings future performance. Hadasit Bio employes about 5 people. The company is managed by 20 executives with total tenure of roughly 74 years, averanging almost 3.0 years of service per executive having 1.0 employee per reported executive. Please also check Risk vs Return Analysis.
  Michel Habib  CEO
  Ophir Shahaf  CEO
  Moise Habib  CEO

Hadasit Bio Management Effectiveness

The company has return on total asset (ROA) of (3.66) % which means that it has lost $3.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (8.9) % meaning that it generated substantial loss on money invested by shareholders.

Hadasit Bio Workforce Comparison

Hadasit Bio Holdings Ltd is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 10.0. Hadasit Bio totals roughly 5.0 in number of employees claiming about 50% of stocks in Biotechnology industry.

Hadasit Bio Profit Margins

The company has Profit Margin (PM) of (126.4) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Hadasit Bio Stakeholders

Michel Habib CEO
Ophir Shahaf CEO
Moise Habib CEO
Baruch Halpert Chairman of the Board
Yoram Azulay Vice President - Finance
Yaakov Naparstek Director
Yigal Erlich Director
Search macroaxis.com